Covidien, a Dublin, Ireland-based global healthcare products company and manufacturer of medical devices and supplies, has acquired California-based Reverse Medical, a privately held medical device company focused on expanding the management of vascular disease. Financial terms of the transaction have not been disclosed.

"Covidien is focused on technologies that deliver improved patient care through clinically relevant and economically valuable solutions," said Brett Wall, president, neurovascular, Covidien. "The acquisition of Reverse Medical is complementary to our existing portfolio and will allow us to leverage existing vascular technologies to compete in the worldwide vascular embolization market, which is growing at a double-digit rate."

Reverse Medical currently is commercializing its vascular embolization plugs, MVP Micro Vascular Plug System and UNO Neurovascular Embolization System. MVP and UNO are self-expanding vessel occlusion devices, which close blood vessels for vascular embolization. A number of clinical applications require occlusion of the vasculature to rapidly, effectively and safely provide blood flow cessation.